Viet Nam News
HCM CITY – Global healthcare company Abbott announced on Tuesday that it has acquired Glomed Pharmaceutical Company Inc (Glomed), a leading Vietnamese drug manufacturer.
It did not disclose the financial details of the deal.
“This acquisition will further strengthen Abbott’s ability to serve patients in Việt Nam with innovative, high-quality healthcare solutions that allow them to live a healthier life and reach their full potential,” Ngô Văn Huy, general manager of Abbott’s pharmaceuticals business, said.
“The company intends to build on Glomed’s success to date to ensure long-term growth in the country.”
The expansion of Abbott’s drug business in Việt Nam builds on its leading position in nutrition and a strong portfolio in medical devices and diagnostics.
The acquisition also makes Abbott one of the top 10 pharmaceutical companies in Việt Nam.
In addition to two manufacturing facilities in Bình Dương Province, Abbott also gains a portfolio of drugs that is well aligned with its current therapeutic areas of focus in anti-infective medicines; gastroenterology; pain management; cardiovascular, respiratory and women’s health; and over-the-counter products. — VNS